A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver

By sjmartinez • December 11, 2024

Perry AS, Hadad N, Chatterjee E, Jimenez-Ramos M, Farber-Eger E, Roshani R, Stolze LK, Betti MJ, Zhao S, Huang S, Martens L, Kendall TJ, Thone T, Amancherla K, Bailin S, Gabriel CL, Koethe J, Carr JJ, Terry JG, Vaitinadin NS, Freedman JE, Tanriverdi K, Alsop E, Van Keuren-Jensen K, Sauld JFK, Mahajan G, Khan SS, Colangelo L, Nayor M, Fisher-Hoch S, McCormick JB, North KE, Below JE, Wells QS, Abel ED, Kalhan R, Scott C, Guilliams M, Gamazon ER, Fallowfield JA, Banovich NE, Das S, Shah R. A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver. Cell Rep Med. 2024 Dec 4:101871. doi: 10.1016/j.xcrm.2024.101871. Epub ahead of print. PMID: 39657669.

Tags: diabetes, Endocrinology, liver-on-a-chip, Metabolic dysfunction-associated steatotic liver disease, non-alcoholic fatty liver disease, proteomics, Publications

Implementation of a cardiovascular toolkit in primary care increased women Veterans’ engagement in behavior change programs: results from a non-randomized stepped wedge trial

Farmer MM, Hamilton AB, Finley EP, Lee ML, Chanfreau C, Than C, Brunner J, Schweizer CA, Moin T, Bean-Mayberry B. Implementation of a cardiovascular toolkit[...]

ERalpha activates NAMPT/IL-33 signaling to enhance beige thermogenesis and metabolic fitness

Hu R, Park J, Qian Y, Xiong S, Elsabbagh AH, Chhikara A, Fan H, Shi Z, Liu L, Li Y, Song Z, Mahmoud AM, Chen[...]

Testosterone deficiency synergistically exacerbates fructose-induced hepatic steatosis through gut microbiota and pyruvate in mice

Takahashi H, Harada N, Hayamizu Y, Dungubat E, Nakazawa M, Kitakaze T, Sugimoto K, Inui H, Yoshihara E, Takahashi Y, Yamaji R. Testosterone deficiency synergistically[...]